期刊文献+

苯那普利对糖尿病大鼠肾脏ColⅣ、FN及NF-κB蛋白表达的影响及其意义 被引量:1

Effects and significance of Benazepril on expression of type Ⅳ collagen and fibronectin and NF-κB in diabetic rats
下载PDF
导出
摘要 目的探讨糖尿病大鼠Ⅳ型胶原(Col Ⅳ)、纤维连接蛋白(FN)及核转录因子kappa B(NF-κB)蛋白的表达及苯那普利对其影响。方法将34只Wistar大鼠随机分为3组:正常对照组(C组)、糖尿病未治疗组(D组)、糖尿病加苯那普利治疗组(B组)。腹腔注射链脲佐菌素(STZ)诱导糖尿病模型。检查各组大鼠在灌胃给药第12周血糖、血肌酐、尿素氮、尿白蛋白及体重等指标变化。应用免疫组织化学检测Col Ⅳ、FN及NF-κB蛋白的表达水平。结果第12周时B组大鼠血糖、血肌酐的浓度及尿蛋白排泄率较D组明显减少(P<0.01<0.05);免疫组织化学显示,B组大鼠肾组织Col Ⅳ、FN及NF-κB蛋白的表达明显低于D组(P<0.01)。结论苯那普利对糖尿病大鼠肾脏具有部分保护作用,其可能抑制血糖浓度升高,下调糖尿病大鼠Col Ⅳ、FN及NF-κB蛋白的表达,减少细胞外基质聚积。 【Objective】 To investigate the mechanisms of Benazepril on the expression of type IV collagen(col Ⅳ),fibronectin(FN) and nuclear factor kappa B(NF-κB) in renal tissue of streptozotocin(STZ) induced diabetic rats.【Methods】 34 Wister rats were randomly divided into three groups: normal control group(C group,n =10),diabetes untreated group(D group,n =12) and diabetes treated with Benazepril(B group,n =12).Diabetes mellitus models were induced by injection of STZ intraperitoneally.Plasma glucose,serum creatinine,blood uria nitrogen,urinary albumin were observed respectively at the twelfth week of treatment,and the expression of type Ⅳ collagen(col Ⅳ),fibronectin(FN) and NF-κB in the kidney were measured by immunohistochemistry.【Results】 At the twelfth week,plasma glucose,creatinine and urinary albumin excretion in B group were significantly lower than those in D group(P 0.01).immunohistochemistry results showed that the expressions of type Ⅳ collagen,fibronectin and NF-κB in renal tissue in B group were much lower than those in D group(P 0.01).【Conclusions】 Benazepril has some renal protective effects on diabetic rats.This might result from decreasing plasma glucose level,down-regulating type Ⅳ collagen,fibronectin and NF-κB expression and reducing the deposition of glomerular extracellular matrix.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第15期1800-1804,共5页 China Journal of Modern Medicine
关键词 Ⅳ型胶原 苯那普利 糖尿病 type Ⅳ collagen Benazepril diabetes mellitus
  • 相关文献

参考文献5

二级参考文献85

  • 1蒋虹,王艳蓉,张永蓉,汪歌.NOD小鼠糖尿病病症的初步观察[J].中国实验动物学杂志,1998,8(3):157-159. 被引量:3
  • 2王新,唐方.单侧肾脏结扎术+链脲佐菌素诱导糖尿病肾病动物模型建立方法的探讨[J].天津医科大学学报,2006,12(1):18-20. 被引量:8
  • 3黄晓丽,吕永曼,易艳,罗建峰.霉酚酸酯在大鼠糖尿病肾病模型中的实验研究[J].中国现代医学杂志,2006,16(16):2464-2467. 被引量:3
  • 4Remuzzi G, Schieppati A, Ruggenenti E Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346: 1145-1151.
  • 5Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G.Lowenfels AB, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000; 35: 157-165.
  • 6Group UKPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
  • 7Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359: 1565-1576.
  • 8Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
  • 9Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
  • 10Yamagishi S, Fukami K, Ueda S, Okuda S. Molecular mechanism of diabetic nephropathy and its therapeutic intervention. Current Drug Targets 2007; 8: 952-959.

共引文献111

同被引文献23

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部